Cite
MLA Citation
Patrice Chevallier et al.. “BCR‐ABL1 molecular remission after 90Y‐epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B‐ALL: proof of principle.” European journal of haematology, vol. 91, n.d., pp. 552–556. http://access.bl.uk/ark:/81055/vdc_100024577255.0x00005f